These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30355683)

  • 1. Structural Basis for Human Norovirus Capsid Binding to Bile Acids.
    Kilic T; Koromyslova A; Hansman GS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human noroviruses' fondness for histo-blood group antigens.
    Singh BK; Leuthold MM; Hansman GS
    J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
    Koromyslova AD; Morozov VA; Hefele L; Hansman GS
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.
    Hansman GS; Biertümpfel C; Georgiev I; McLellan JS; Chen L; Zhou T; Katayama K; Kwong PD
    J Virol; 2011 Jul; 85(13):6687-701. PubMed ID: 21525337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Blockade of the Norovirus Histo-Blood Group Antigen Binding Pocket by Nanobodies.
    Kher G; Sabin C; Lun JH; Devant JM; Ruoff K; Koromyslova AD; von Itzstein M; Pancera M; Hansman GS
    J Virol; 2023 Apr; 97(4):e0183322. PubMed ID: 36971561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens.
    Leuthold MM; Dalton KP; Hansman GS
    J Virol; 2015 Feb; 89(4):2378-87. PubMed ID: 25505081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
    Koromyslova AD; Hansman GS
    PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for norovirus inhibition and fucose mimicry by citrate.
    Hansman GS; Shahzad-Ul-Hussan S; McLellan JS; Chuang GY; Georgiev I; Shimoike T; Katayama K; Bewley CA; Kwong PD
    J Virol; 2012 Jan; 86(1):284-92. PubMed ID: 22031945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses.
    Hansman GS; Kher G; Svirina AD; Tame JRH; Hartley-Tassell L; Irie H; Haselhorst T; von Itzstein M; Rudd PA; Pancera M
    J Virol; 2024 Jul; 98(7):e0070724. PubMed ID: 38953655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.
    Shanker S; Choi JM; Sankaran B; Atmar RL; Estes MK; Prasad BV
    J Virol; 2011 Sep; 85(17):8635-45. PubMed ID: 21715503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis of Nanobodies Targeting the Prototype Norovirus.
    Ruoff K; Kilic T; Devant J; Koromyslova A; Ringel A; Hempelmann A; Geiss C; Graf J; Haas M; Roggenbach I; Hansman G
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
    Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
    Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Norovirus Interactions with Histo-Blood Group Antigens and Human Milk Oligosaccharides.
    Schroten H; Hanisch FG; Hansman GS
    J Virol; 2016 Jul; 90(13):5855-5859. PubMed ID: 27122582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
    Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
    Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sweet quartet: Binding of fucose to the norovirus capsid.
    Koromyslova AD; Leuthold MM; Bowler MW; Hansman GS
    Virology; 2015 Sep; 483():203-8. PubMed ID: 25980740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.
    Shanker S; Czako R; Sankaran B; Atmar RL; Estes MK; Prasad BV
    J Virol; 2014 Jun; 88(11):6168-80. PubMed ID: 24648450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths.
    Qian Y; Song M; Jiang X; Xia M; Meller J; Tan M; Chen Y; Li X; Rao Z
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30333166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human norovirus inhibition by a human milk oligosaccharide.
    Koromyslova A; Tripathi S; Morozov V; Schroten H; Hansman GS
    Virology; 2017 Aug; 508():81-89. PubMed ID: 28505592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile Facilitates Human Norovirus Interactions with Diverse Histoblood Group Antigens, Compensating for Capsid Microvariation Observed in 2016-2017 GII.2 Strains.
    Mallory ML; Lindesmith LC; Brewer-Jensen PD; Graham RL; Baric RS
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.